Log In
BCIQ
Print this Print this
 

Orapred ODT, prednisolone

  Manage Alerts
Collapse Summary General Information
Company Concordia International Corp.
DescriptionOrally disintegrating tablet of a corticosteroid
Molecular Target Corticoid receptors
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAsthma
Indication DetailsReduce inflammation due to asthma, arthritis or cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
Get a free BioCentury trial today